Showing results (101-110 of 279) with videos related to
Sort By:
Pageof 28
Therapeutics and Clinical Risk Management|March 25, 2008
Progress in the development of a cervical cancer vaccineUrsula Winters, Richard Roden, Henry Kitchener, et al.Plos Pathogens|August 19, 2016
A Drosophila Model of HPV E6-Induced Malignancy Reveals Essential Roles for Magi and the Insulin ReceptorMojgan Padash Barmchi, Mary Gilbert, Miranda Thomas, et al.Journal of Virology|July 22, 2011
Systematic analysis of the amino acid residues of human papillomavirus type 16 E7 conserved region 3 involved in dimerization and transformationBiljana Todorovic, Paola Massimi, Katherine Hung, et al.Traffic (Copenhagen, Denmark)|December 14, 2011
Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17Martina Bergant Marušič, Michelle A Ozbun, Samuel K Campos, et al.Experimental Cell Research|September 17, 2008
Regulation of the hDlg/hScrib/Hugl-1 tumour suppressor complexPaola Massimi, Nisha Narayan, Miranda Thomas, et al.Oncogene|July 26, 2002
Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradationMiranda Thomas, Richard Laura, Karin Hepner, et al.Journal of Virology|February 3, 2007
Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoproteinYi Zhang, Jhimli Dasgupta, Runlin Z Ma, et al.Journal of Virology|June 14, 2024
HPV-18 E6 enhances the interaction between EMILIN2 and SNX27 to promote WNT signalingJustyna Broniarczyk, Oscar Trejo-Cerro, Paola Massimi, et al.Journal of Virology|January 20, 2017
The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7Anita Szalmás, Vjekoslav Tomaić, Om Basukala, et al.Virology|June 4, 2008
The E6E7 oncoproteins of cutaneous human papillomavirus type 38 interfere with the interferon pathwayPablo Cordano, Victoria Gillan, Sigrid Bratlie, et al.Pageof 28